Impact of HIV on childhood respiratory illness: differences between developing and developed countries

S M Graham1

  • 1Malawi-Liverpool-Wellcome Trust Clinical Research Programme and Department of Paediatrics, College of Medicine, University of Malawi, Blantyre, Malawi. sgraham@mlw.medcol.mw

Pediatric Pulmonology
|November 18, 2003
PubMed

Insights

HIV significantly impacts childhood respiratory illness in Africa due to resource limitations. Patterns resemble pre-antiretroviral therapy eras, with bacterial pneumonia, Pneumocystis jiroveci pneumonia (PCP), and tuberculosis being common.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • HIV's impact on childhood respiratory illness varies globally, particularly in resource-limited African settings.
  • Challenges in prevention, diagnosis, and management exacerbate the problem in developing countries.

Purpose of the Study:

  • To review current data on respiratory diseases in HIV-infected African children.
  • To compare these patterns with those observed in developed countries before widespread antiretroviral therapy.

Main Methods:

  • Review of recent data on respiratory illnesses in HIV-infected African children.
  • Comparison with historical data from the USA and Europe.

Main Results:

  • Respiratory disease patterns in HIV-infected African children are similar to pre-antiretroviral therapy eras in developed nations.
  • Bacterial pneumonia is highly prevalent across all age groups.
  • Pneumocystis jiroveci pneumonia (PCP) and cytomegalovirus (CMV) are common in infants, while lymphoid interstitial pneumonitis (LIP) affects older children.
  • Pulmonary tuberculosis (PTB) is more frequent in HIV-infected African children, likely due to higher regional prevalence.

Conclusions:

  • Resource limitations in Africa amplify the burden of HIV-related childhood respiratory illness.
  • Clinical presentation shares similarities with historical data from developed countries.
  • Further prospective clinical and intervention studies are crucial for improving diagnosis and management in the region.

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...